Sort
23,748 grants matching “melanoma”
The role of macroH2A-ZMYM3 in genome stability and tumorigenesis
$179,388Justin Wai Chung Leung · Univ Of Arkansas For Med Scis · K22 · FY2020 · CA
The role of macroH2A-ZMYM3 in genome stability and tumorigenesis
$179,388Justin Wai Chung Leung · Univ Of Arkansas For Med Scis · K22 · FY2019 · CA
Multimodal multifocal confocal Raman and phase microscopy with enhanced resolution
$179,369Peter T. So · Massachusetts Institute Of Technology · P41 · FY2018 · EB
Therapuetic Immune Targeting of EphA2 Expressed by Melanoma & Its Tumor-Associate
$179,361Walter J Storkus · University Of Pittsburgh At Pittsburgh · P50 · FY2010 · CA
Laboratory Core
$179,316John T. West · University Of Nebraska Lincoln · U54 · FY2018 · CA
Combination Therapy to Improve MAPK Pathway Inhibitor Efficacy in BRAF and KRAS M
$179,280Ryan Bruce Corcoran · Massachusetts General Hospital · K08 · FY2014 · CA
Combination Therapy to Improve MAPK Pathway Inhibitor Efficacy in BRAF and KRAS M
$179,280Ryan Bruce Corcoran · Massachusetts General Hospital · K08 · FY2013 · CA
Combination Therapy to Improve MAPK Pathway Inhibitor Efficacy in BRAF and KRAS M
$179,280Ryan Bruce Corcoran · Massachusetts General Hospital · K08 · FY2015 · CA
Combination Therapy to Improve MAPK Pathway Inhibitor Efficacy in BRAF and KRAS M
$179,280Ryan Bruce Corcoran · Massachusetts General Hospital · K08 · FY2016 · CA
Combination Therapy to Improve MAPK Pathway Inhibitor Efficacy in BRAF and KRAS M
$179,280Ryan Bruce Corcoran · Massachusetts General Hospital · K08 · FY2017 · CA
Core C - Cell Culture Core
$179,232Yale University · P30 · FY2005 · AR
Core C - Cell Culture Core
$179,232Ruth Halaban · Yale University · P30 · FY2006 · AR
Core C - Cell Culture Core
$179,232Yale University · P30 · FY2004 · AR
MECHANISMS OF NK CELL RECRUITMENT TO SITES OF TUMOR
$179,222University Of Pittsburgh At Pittsburgh · P01 · FY2000 · CA
Mechanisms of cooperation between MAPK and PI3K signaling in melanoma
$179,070Jillian Silva · University Of California, San Francisco · K01 · FY2020 · CA
Targeting defective spliceosomal pathway in myeloid malignancies
$178,991Chao-Yie Yang · University Of Tennessee Health Sci Ctr · R21 · FY2023 · CA
Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors
$178,985Rosa Maria Diaz · Vyriad, Inc. · R44 · FY2018 · CA
Using MC1R genotype to impact skin cancer risk behaviors in Hispanics/Latinos
$178,950Brenda Soto-Torres · Ponce School Of Medicine · U54 · FY2018 · CA
WNT GENES AND SIGNALING IN XENOPUS
$178,946University Of Washington · R01 · FY2001 · HD
Experimental Pathology
$178,943Kam-Meng Tchou-Wong · New York University School Of Medicine · P30 · FY2010 · CA
Data Bank & BioRepository
$178,907Christine B. Ambrosone · Roswell Park Cancer Institute Corp · P30 · FY2011 · CA
Mechanisms of Th17-DC immunotherapy for ovarian cancer
$178,819Martin J Cannon · Univ Of Arkansas For Med Scis · R21 · FY2025 · CA
Inducing Chromosomal Damage Responses in Pancreatic Cancer
$178,750Douglas V Faller · Boston University Medical Campus · R21 · FY2009 · CA
Suppression of Cancer Inflammation with AHR Modulators
$178,723Adam B Glick · Pennsylvania State University, The · R21 · FY2012 · ES
Therapuetic Immune Targeting of EphA2 Expressed by Melanoma & Its Tumor-Associate
$178,711Walter J Storkus · University Of Pittsburgh At Pittsburgh · P50 · FY2009 · CA